Company / Profit Margin
TEVA PHARMACEUTICAL INDUSTRIES LTD Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
8.2%
FY2025
5-year range
-16.4% / 8.2%
FY2021-FY2025
Trend
+182.4%
vs FY2024
Sector context
#43 of 145
Health Care
What the data says
At 8.2%, TEVA PHARMACEUTICAL INDUSTRIES LTD's profit margin ranks #43 of 145 in the Health Care sector. Profit Margin has fluctuated over the past 9 years, ranging from -23.9% in FY2020 to 8.2% in FY2025.
Based on SEC 10-K filings.
8.2% in FY2025 with a 5-year CAGR of +32.1%.
Improved from -3.5% to 8.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +24.6pp
- 5-Year Change
- +32.1pp
- 10-Year Change
- -
Sector benchmark
#43 of 145 in Health CareTop 30% of 145This company 8.2% Sector average -792.7%
▼
+101.0% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 182.4% year-over-year.
- Currently 800.9pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.2% | +182.4% |
| FY2024 | -9.9% | -180.7% |
| FY2023 | -3.5% | +78.5% |
| FY2022 | -16.4% | -723.2% |
| FY2021 | 2.6% | +111.0% |
| FY2020 | -23.9% | -304.6% |
| FY2019 | -5.9% | +49.7% |
| FY2018 | -11.8% | - |
| FY2017 | - | - |
| FY2016 | 1.5% | -81.4% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026